Gene therapy aimed at promoting muscle growth improved the walking ability of three of the first four Becker muscular dystrophy patients given the treatment, researchers from Nationwide Children's Hospital reported at the Child Neurology Society's annual meeting. Dr. Mustafa Sahin of Boston Children's Hospital said these types of new molecular therapies "have the potential to change the natural history of the disease."

Related Summaries